ArticlePharmaceutics2022

Celecoxib Microparticles for Inhalation in COVID-19-Related Acute Respiratory Distress Syndrome.

Monica-Carolina Villa-Hermosilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.